Last reviewed · How we verify
NCT03690492
The Box 2.0: Using Smart Technology for Early Diagnosis of Complications After Cardiovascular Surgery
NA trial testing The Box 2.0 in Rehabilitation After Cardiovascular Surgery in 730 participants. Completed in 15 June 2021.
15 March 2021
Quick facts
| Lead sponsor | Leiden University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 730 |
| Start date | 2 October 2018 |
| Primary completion | 15 March 2021 |
| Estimated completion | 15 June 2021 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- The Box 2.0
Conditions studied
- Rehabilitation After Cardiovascular Surgery — all drugs for Rehabilitation After Cardiovascular Surgery →
- Mobile Health — all drugs for Mobile Health →
Sponsor
Leiden University Medical Center
Who can join
18 and older, any sex, with Rehabilitation After Cardiovascular Surgery or Mobile Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to determine the effect on quality of care when introducing smart technology in patients who underwent cardiovascular surgery. Patients who consent to take part in the study, receive a box containing two smartphone compatible ECG monitors, an oxygen saturation monitor, a weight scale, a thermometer, an activity tracker and a blood pressure monitor. They will be followed up by replacing one of the outpatient clinic visits by an e-consult, in which a patients does not have to go to the hospital. Instead, he or she will talk with his or her doctor or nurse practitioner via a secured video connection. The primary endpoint of the study will be the diagnosis of atrial fibrillation within 3 months after cardiac surgery.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Use of Smart Technology for the Early Diagnosis of Complications After Cardiac Surgery: The Box 2.0 Study Protocol.
Biersteker TE, Boogers MJ, de Lind van Wijngaarden RA, Groenwold RH, et al · · 2020 · cited 11× · PMID 32314974 · DOI 10.2196/16326 -
Mobile health vs. standard care after cardiac surgery: results of The Box 2.0 study.
Biersteker TE, Boogers MJ, Schalij MJ, Penning de Vries BBL, et al · · 2023 · cited 8× · PMID 35951658 · DOI 10.1093/europace/euac115 -
Real-World Experience of mHealth Implementation in Clinical Practice (the Box): Design and Usability Study.
Biersteker T, Hilt A, van der Velde E, Schalij MJ, et al · · 2021 · cited 4× · PMID 34642159 · DOI 10.2196/26072 -
Mobile health for cardiovascular risk management after cardiac surgery: results of a sub-analysis of The Box 2.0 study.
Biersteker TE, Boogers MJ, Schalij MJ, Braun J, et al · · 2023 · PMID 37538141 · DOI 10.1093/ehjdh/ztad035
Verify or expand the search:
- PubMed search for NCT03690492
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Leiden University Medical Center trials
Trials by the same sponsor.
- NCT07312565 — Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage · not yet recruiting
- NCT07090343 — Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement · Phase 3 · not yet recruiting
- NCT07498738 — Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions · NA · not yet recruiting
- NCT06545292 — Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients · NA · recruiting
- NCT07021495 — SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03690492 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Leiden University Medical Center
- Last refreshed: 8 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03690492.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing